Identification of an interaction between VWF rs7965413 and platelet count as a novel risk marker for metabolic syndrome: An extensive search of candidate polymorphisms in a case-control study

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Nakatochi, Masahiro ^a   Ushida, Yasunori ^b   Yasuda, Yoshinari ^c   Yoshida, Yasuko ^b   Kawai, Shun ^b   Kato, Ryuji ^b   Nakashima, Toru ^d   Iwata, Masamitsu ^d   Kuwatsuka, Yachiyo ^a   Ando, Masahiko ^a   Hamajima, Nobuyuki ^c   Kondo, Takaaki ^c   Oda, Hiroaki ^b   Hayashi, Mutsuharu ^e   Kato, Sawako ^c   Yamaguchi, Makoto ^c   Maruyama, Shoichi ^c   Matsuo, Seiichi ^c   Honda, Hiroyuki ^b  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOYOTA MOTOR CORPORATION   (Japan)

^e FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; INSULIN RECEPTOR SUBSTRATE 2; UNCOUPLING PROTEIN 1; VON WILLEBRAND FACTOR;

ADULT; APOA5 GENE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; EMPLOYEE; GENE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; IRS2 GENE; JAPANESE (PEOPLE); LRP2 GENE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MYO16 GENE; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TBC1D9 GENE; THROMBOCYTE COUNT; UCP1 GENE; VWF GENE; BLOOD; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLATELET COUNT; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VON WILLEBRAND FACTOR;

EID: 84922358051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117591     Document Type: Article

References (44)

1. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414. PMID: 17258085
2. McCurry J (2004) Japanese people warned to curb unhealthy lifestyles. Health experts urge a return to dietary basics to prevent future health problems. Lancet 363:1126. PMID: 15068019
3. Ministry of Health, Labour and Welfare of Japan (2007) Outline for the results of the national health and nutrition survey Japan, 2007 Available: http://www0.nih.go.jp/eiken/english/research/pdf/nhns2007. pdf. Accessed 4 July 2014. doi: 10.1093/jxb/erm028 PMID: 25506957
4. Ministry of Health, Labour and Welfare of Japan (2007) Chapter 4: Future health promotion and medicine-reforming the medical architecture. In: The white paper of the Ministry of Health and Welfare in Heisei 19. In: Kyokai Kousei Toukei, editor. Tokyo. pp. 97-161.
5. Ushida Y, Kato R, Niwa K, Tanimura D, Izawa H, et al. (2012) Combinational risk factors of metabolic syndrome identified by fuzzy neural network analysis of health-check data. BMC Med Inform Decis Mak 12:80. doi: 10.1186/1472-6947-12-80 PMID: 22853735
6. Wu S, Lin H, Zhang C, Zhang Q, Zhang D, et al. (2013) Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. BMC Public Health 13:989. doi: 10.1186/1471-2458-13-989 PMID: 24144016
7. Tao LX, Li X, Zhu HP, Huo D, Zhou T, et al. (2013) Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study. Endocrine. doi: 10.1007/s12020-013- 0144-3 PMID: 24366647
8. Nakatochi M, Miyata S, Tanimura D, Izawa H, Asano H, et al. (2011) The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study. Diabetes Res Clin Pract 92: e61-65. doi: 10.1016/j.diabres.2011.02.029 PMID: 21458098
9. Povel CM, Boer JM, Reiling E, Feskens EJ (2011) Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 12: 952-967. doi: 10.1111/j.1467-789X.2011.00907.x PMID: 21749608
10. Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, et al. (2012) Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet 5: 242-249. doi: 10.1161/CIRCGENETICS.111.961482 PMID: 22399527
11. Zabaneh D, Balding DJ (2010) A genome-wide association study of the metabolic syndrome in Indian Asian men. PLoS One 5: e11961. doi: 10.1371/journal.pone.0011961 PMID: 20694148
12. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367. doi: 10.1073/pnas.0903103106 PMID: 19474294
13. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, et al. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359: 2220-2232. doi: 10.1056/ NEJMoa0801869 PMID: 19020324
14. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935. PMID: 11344187
15. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, et al. (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 44: 659-669. doi: 10.1038/ng.2274 PMID: 22581228
16. Examination Committee of Criteria for the Metabolic Syndrome in Japan (2005) Metabolic syndrome-definition and diagnostic criteria in Japan. J Jpn Soc Int Med 94: 188-203. (in Japanese)
17. Nishida N, Tanabe T, Takasu M, Suyama A, Tokunaga K (2007) Further development ofmultiplex single nucleotide polymorphism typing method, the DigiTag2 assay. Anal Biochem 364: 78-85. PMID: 17359929
18. Aiken LS, West SG, Reno RR (1991) Multiple regression: testing and interpreting interactions. Newbury Park, Calif.: Sage Publications. xi, 212 p.
19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. PMID: 17701901
20. Willer CJ, Li Y, Abecasis GR (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26: 2190-2191. doi: 10.1093/bioinformatics/btq340 PMID: 20616382
21. Nebeck K, Gelaye B, Lemma S, Berhane Y, Bekele T, et al. (2012) Hematological parameters and metabolic syndrome: findings from an occupational cohort in Ethiopia. Diabetes Metab Syndr 6: 22-27. doi: 10.1016/j.dsx.2012.05.009 PMID: 23014250
22. Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, et al. (2003) Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 52: 1246-1249. PMID: 14564674
23. Ruggeri ZM, Ware J (1993) von Willebrand factor. FASEB J 7: 308-316. PMID: 8440408
24. Vischer UM (2006) von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 4: 1186-1193. PMID: 16706957
25. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, et al. (2000) Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283: 221-228. PMID: 10634338
26. Ragab A, Abousamra NK, Higazy A, Saleh O (2008) Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome. Lab Hematol 14: 1-6. doi: 10.1532/LH96.07017 PMID: 18403313
27. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96: 1102-1108. PMID: 9286936
28. Whincup PH, Danesh J, WalkerM, Lennon L, Thomson A, et al. (2002) vonWillebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 23: 1764-1770. PMID: 12419296
29. Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D (1999) Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 93: 4277-4283. PMID: 10361125
30. van der Meer IM, Brouwers GJ, Bulk S, Leebeek FW, van der Kuip DA, et al. (2004) Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study. Br J Haematol 124: 343-347. PMID: 14717782
31. Di Bitondo R, Cameron CL, Daly ME, Croft SA, Steeds RP, et al. (2001) The-1185 A/G and-1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarction. Br J Haematol 115: 701-706. PMID: 11736957
32. Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, et al. (2011) New gene functions in megakaryopoiesis and platelet formation. Nature 480: 201-208. doi: 10.1038/nature10659 PMID: 22139419
33. Ruixing Y, Jinzhen W, Shangling P, Weixiong L, Dezhai Y, et al. (2008) Sex differences in environmental and genetic factors for hypertension. Am J Med 121: 811-819. doi: 10.1016/j.amjmed.2008.04.026 PMID: 18724972
34. Defago MD, Gu D, Hixson JE, Shimmin LC, Rice TK, et al. (2013) Common genetic variants in the endothelial system predict blood pressure response to sodium intake: the GenSalt study. Am J Hypertens 26: 643-656. doi: 10.1093/ajh/hps099 PMID: 23443727
35. Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, et al. (2007) Prediction of genetic risk for metabolic syndrome. Atherosclerosis 191: 298-304. PMID: 16806226
36. Xu C, Bai R, Zhang D, Li Z, Zhu H, et al. (2013) Effects of APOA5-1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a metaanalysis. PLoS One 8: e56216. doi: 10.1371/journal.pone.0056216 PMID: 23468858
37. Grallert H, Sedlmeier EM, Huth C, Kolz M, Heid IM, et al. (2007) APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res 48: 2614-2621. PMID: 17768309
38. Paulik MA, Buckholz RG, Lancaster ME, Dallas WS, Hull-Ryde EA, et al. (1998) Development of infrared imaging to measure thermogenesis in cell culture: thermogenic effects of uncoupling protein-2, troglitazone, and beta-adrenoceptor agonists. Pharm Res 15: 944-949. PMID: 9647363
39. Jia JJ, Tian YB, Cao ZH, Tao LL, Zhang X, et al. (2010) The polymorphisms of UCP1 genes associated with fat metabolism, obesity and diabetes. Mol Biol Rep 37: 1513-1522. doi: 10.1007/s11033-009- 9550-2 PMID: 19444646
40. Dalgaard LT, Pedersen O (2001) Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia 44: 946-965. PMID: 11484071
41. Kamatani Y, Matsuda K, Okada Y, Kubo M, Hosono N, et al. (2010) Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 42: 210-215. doi: 10.1038/ ng.531 PMID: 20139978
42. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, et al. (2009) Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58: 1403-1410. doi: 10.2337/db08-1514 PMID: 19252134
43. Maeda S, Araki S, Babazono T, Toyoda M, Umezono T, et al. (2010) Replication study for the association between four loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes 59: 2075-2079. doi: 10.2337/db10-0067 PMID: 20460425
44. Maric C, Hall JE (2011) Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol 170: 28-35. doi: 10.1159/000324941 PMID: 21659755